IPF: Know the Symptoms
Learn more about IPF:https://bit.ly/1QiRmr3…
IPF: Know the Symptoms
Causes of Idiopathic Pulmonary Fibrosis
“Professor Ulrich Costabel, from the Department of Pneymonology and Allergology, Ruhrlandklinik, Essen, discusses some questions and possible causes of idiopathic pulmonary fibrosis (IPF).” Read more about pulmonary fibrosis:Â https://bit.ly/1lfMsiZ…
What is Pulmonary Rehabilitation? – Pulmonary Fibrosis
Learn more about pulmonary fibrosis:Â https://bit.ly/1lfMsiZ…
Dr. Gerard Criner About Pulmonary Fibrosis
“Kearni Warren sits down with Gerard Criner, M.D. to learn more about pulmonary fibrosis and some of the treatment options for patients.” Learn more about pulmonary fibrosis:Â https://bit.ly/1lfMsiZ…
Country Music Star Joe Nichols Shares His Dad’s IPF Story in ‘Breathless,’ a Public Awareness Campaign
Country music artist Joe Nichols is partnering with Boehringer Ingelheim to raise awareness about idiopathic pulmonary fibrosis (IPF). Nichols’ father, Michael Nichols, suffered with IPF symptoms for three years before receiving the diagnosis, and he died from the condition at age 46. As part of a national education campaign called Breathless: A…
Type V Collagen Autoimmunity & Idiopathic Pulmonary Fibrosis (IPF)
Learn more about idiopathic pulmonary fibrosis:Â https://bit.ly/1QiRmr3…
Last Week’s Hot Topic on Pulmonary Fibrosis
Last week’s hot topic on pulmonary fibrosis was Traditional Chinese Medicine Eased Inflammation, Fibrosis in Animal PF Model written by Magdalena Kegel. This articles focus on a study from the University of Madras, India, which showed that celastrol — a component of an extract from the Thunder…
For Treating Pulmonary Fibrosis and Other Diseases, Capsugel and Pulmatrix Collaborate on Inhaled Therapeutics
Morristown, New Jersey-based Capsugel, a provider of empty two-piece hard capsules and an innovator of drug delivery systems, and Pulmatrix, of Lexington, Massachusetts — a clinical-stage biopharmaceutical company and developer of inhaled therapies for treating pulmonary fibrosis and other pulmonary diseases with its patented iSPERSE technology, are collaborating to develop…
Apellis to Move IPF Immunotherapy into Testing with $47.1M Series D Financing
Apellis Pharmaceuticals, Inc., recently announced that it has completed a $47.1 million Series D preferred stock financing, which will be used to advance clinical trials into the company’s complement immunotherapy programs for diseases that include idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). The complement system is part of…
Pulmonary Fibrosis: Clearing Your Chest with Breathing Exercises
In this video from 2013, by NHS Forth Valley, meet Dawn Gleen, a physiotherapist who has a special interest in people who have chest conditions. If you suffer from pulmonary fibrosis or other lung diseases, watch the video to learn some tips on how you can help to clear your…
